Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPEAT: Pegasys Retreatment in HCV Non-Responders
NCT00087646Phase 4Completed
- Sponsor
- Roche
- Start
- Sep 2003
- Primary completion
- May 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 14
01
Overview
A Phase 4 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Roche. Started Sep 2003; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00087646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087646.